Compugen
CGEN
#8642
Rank
โ‚ฌ0.20 B
Marketcap
2,18ย โ‚ฌ
Share price
6.41%
Change (1 day)
69.58%
Change (1 year)

Revenue for Compugen (CGEN)

Revenue in 2026 (TTM): โ‚ฌ61.87 Million

According to Compugen's latest financial reports the company's current revenue (TTM ) is โ‚ฌ63.64 Million. In 2025 the company made a revenue of โ‚ฌ61.94 Million an increase over the revenue in the year 2024 that were of โ‚ฌ26.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Compugen from 2000 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ61.87 M-0.11%
2025 โ‚ฌ61.94 M131.33%
2024 โ‚ฌ26.77 M-11.53%
2023 โ‚ฌ30.26 M332.89%
2022 โ‚ฌ6.99 M31.97%
2021 โ‚ฌ5.29 M225.82%
2020 โ‚ฌ1.62 M
2019 N/A-100%
2018 โ‚ฌ15.55 M
2017 N/A-100%
2016 โ‚ฌ0.67 M-92.02%
2015 โ‚ฌ8.48 M-16.55%
2014 โ‚ฌ10.16 M295.68%
2013 โ‚ฌ2.56 M1304.69%
2012 โ‚ฌ0.18 M
2011 N/A-100%
2010 โ‚ฌ0.83 M380.4%
2009 โ‚ฌ0.17 M-27.83%
2008 โ‚ฌ0.24 M
2004 โ‚ฌ2.96 M-57.65%
2003 โ‚ฌ7.01 M-33.96%
2002 โ‚ฌ10.61 M-17.47%
2001 โ‚ฌ12.86 M66.93%
2000 โ‚ฌ7.7 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
โ‚ฌ2.01 B 3,066.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
โ‚ฌ14.98 M-76.46%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚ฌ15.19 B 23,776.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Eterna Therapeutics
ERNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA